Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Loyalloyal.com · Low evidenceLoyal is developing the first longevity drugs for dogs, targeting the underlying processes of aging to increase healthy lifespan. Their lead drug, LOY 002, aims to extend lifespan and maintain quality of life in senior dogs by addressing age-associated metabolic dysfunction.
Parse Score